Thyme Care has raised $125 million from investors in a deal doubling the cancer startup's valuation as it tackles critical disease treatment gaps.
<iframe src="https://statesidedaily.com/embed/cluster/462bc874aa0c1e435c138ddd6d3b017b50aebc7a" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Thyme Care raises $125 million, pushing cancer care startup's valuation above $2 billion"></iframe>
Thyme Care has raised $125 million from investors in a deal doubling the cancer startup's valuation as it tackles critical disease treatment gaps.
